Journal
JOURNAL OF CLINICAL MEDICINE
Volume 9, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jcm9061900
Keywords
endometrial cancer; protein biomarker; prognostic; prognosis; risk assessment; ESMO-ESGO-ESTRO risk classification; TCGA; endometrial adenocarcinoma; uterine cancer; recurrence
Categories
Funding
- CIBERONC [CB16/12/00328]
- Fondo Europeo de Desarrollo Regional FEDER [RTC-2015-3821-1]
- Asociacion Espanola Contra el Cancer [GCTRA1804MATI]
- Grups consolidats de la Generalitat de Catalunya [2017 SGR-1661]
- Instituto de Salud Carlos III [DTS17/00146, PI17/02071, PI17/02155, IFI19/00029]
- Generalitat de Catalunya [SLT002/16/00315]
- Televie [F5/20/5-TLV/DD]
Ask authors/readers for more resources
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these systems remain inaccurate. Therefore, identifying prognostic EC biomarkers is crucial for improving risk assessment pre- and postoperatively and to guide treatment decisions. This systematic review gathers all protein biomarkers associated with clinical prognostic factors of EC, recurrence and survival. Relevant studies were identified by searching the PubMed database from 1991 to February 2020. A total number of 398 studies matched our criteria, which compiled 255 proteins associated with the prognosis of EC. MUC16, ESR1, PGR, TP53, WFDC2, MKI67, ERBB2, L1CAM, CDH1, PTEN and MMR proteins are the most validated biomarkers. On the basis of our meta-analysis ESR1, TP53 and WFDC2 showed potential usefulness for predicting overall survival in EC. Limitations of the published studies in terms of appropriate study design, lack of high-throughput measurements, and statistical deficiencies are highlighted, and new approaches and perspectives for the identification and validation of clinically valuable EC prognostic biomarkers are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available